WilliamLCarrollMD
Family Medicine • West Chester, PAAssistant Clinical Professor of Family Medicine, Thomas Jefferson University
Are you Dr. Carroll?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 73 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1240 Wrights LN
West Chester, PA 19380Phone+1 610-431-1210Fax+1 610-594-2625- Is this information wrong?
Summary
- Dr. William Carroll, MD is a board certified family physician in West Chester, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and Delaware. He is affiliated with Paoli Hospital and Bryn Mawr Hospital.
Education & Training
Christiana Care Health ServicesResidency, Family Medicine, 1989 - 1992
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1989
Certifications & Licensure
PA State Medical License 1992 - 2024
DE State Medical License 1991 - 1995- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2004-2014
- America's Top Doctors Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2002-2009, 2013-2014
- Join now to see all
Clinical Trials
- EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2010 Aug 24
Publications & Presentations
PubMed
- Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.Wong, J. C.,Bryant, V.,Lamprecht, T.,Ma, J.,Walsh, M.,Schwartz, J.,Del Pilar Alzamora, M.,Mullighan, C. G.,Loh, M. L.,Ribeiro, R.,Downing, J. R.,Carroll, W. L.,Davis, ...> ;JCI Insight. 2018 Jul 27
- MSH6 Haploinsufficiency at Relapse Contributes to the Development of Thiopurine Resistance in Pediatric B-lymphoblastic LeukemiaWilliam L Carroll, P Pallavi Madhusoodhan, David J Araten, Stephen P Hunger, Teena Bhatla, David Teachey> ;Haematologica. 2018 Feb 17
- Beating the Clock in T-cell Acute Lymphoblastic LeukemiaWilliam L Carroll, Elizabeth Raetz> ;Clinical Cancer Research. 2016-12-22
- Join now to see all
Grant Support
- Drug Resistant Pathways In Relapsed Acute Lymphoblastic Leukemia(All)National Cancer Institute2010–2012
- SR. LeadershipNational Cancer Institute2008–2012
- Planning And EvaluationNational Cancer Institute2008–2012
- Cancer Center Support GrantNational Cancer Institute2007–2012
- Integrated Genomics Profile Of Relapsed Childhood Acute Lymphoblastic LeukemiaNational Cancer Institute2010–2011
- DevelopmentNational Cancer Institute2008–2009
- AdministrationNational Cancer Institute2008–2009
- Post Transcriptional Control Of The Human N MYC GeneNational Cancer Institute2002
- Post Transcriptional Control Of The Human N MYC GeneNational Cancer Institute2000–2001
- Childrens Cancer GroupNational Cancer Institute1999–2001
- Cell Differentiation And Ontogeny Of HematopoiesisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
- Molecular Basis Of Immunoglobulin Gene HypermutationNational Cancer Institute1992–1994
- Molecular Basis Of Immunoglobulin Gene HypermutationNational Cancer Institute1990–1991
- NCI Clinical Investigator Award ProgramNational Cancer Institute1987
- NCI Clinical Investigator Award ProgramNational Cancer Institute1985–1986
Hospital Affiliations
Bryn Mawr HospitalBryn Mawr, Pennsylvania
Paoli HospitalPaoli, Pennsylvania
